New Alzheimer's Drug Slows Disease in Early Stages
Patients with early Alzheimer's now have access to Kisunla, an FDA-approved therapy that slows disease progression and helps people maintain independence longer. UToledo Health is offering the treatment, marking a major shift from managing symptoms to actually slowing the disease itself.
